140 related articles for article (PubMed ID: 36409032)
1. RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study.
Chlebowski RT; Aragaki AK; Pan K
J Natl Cancer Inst; 2023 Feb; 115(2):222-223. PubMed ID: 36409032
[No Abstract] [Full Text] [Related]
2. RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study.
Pederson HJ; Faubion SS; Pruthi S; Goldfarb S
J Natl Cancer Inst; 2023 Feb; 115(2):220-221. PubMed ID: 36409007
[No Abstract] [Full Text] [Related]
3. RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study.
Van Cauwenberge J; Borremans K; Van Houdt M; Deblander A; Berteloot P; Han S; Laenen A; Neven P
J Natl Cancer Inst; 2023 Aug; 115(8):998-999. PubMed ID: 37216905
[No Abstract] [Full Text] [Related]
4. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapy--a prospective observational study.
Stahlberg C; Lynge E; Andersen ZJ; Keiding N; Ottesen B; Rank F; Hundrup YA; Obel EB; Pedersen AT
Int J Epidemiol; 2005 Aug; 34(4):931-5. PubMed ID: 15914504
[No Abstract] [Full Text] [Related]
6. [The Danish Nurse Cohort Study 1993-2003].
Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
[No Abstract] [Full Text] [Related]
7. Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors.
Moegele M; Buchholz S; Seitz S; Ortmann O
Arch Gynecol Obstet; 2012 May; 285(5):1397-402. PubMed ID: 22212649
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy in patients with early breast cancer.
Natrajan PK; Gambrell RD
Am J Obstet Gynecol; 2002 Aug; 187(2):289-94; discussion 294-5. PubMed ID: 12193914
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and hormone replacement therapy.
Lancet; 1990 Feb; 335(8684):297-8. PubMed ID: 1967758
[No Abstract] [Full Text] [Related]
11. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews CA; Chlebowski RT; Stefanick ML; Lane DS; Shifren J; Chen C; Kaunitz AM; Cauley JA; Manson JE
Menopause; 2018 Jan; 25(1):11-20. PubMed ID: 28816933
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.
Dew JE; Wren BG; Eden JA
Climacteric; 2003 Mar; 6(1):45-52. PubMed ID: 12725664
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
[TBL] [Abstract][Full Text] [Related]
14. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
16. Cohort profile: the Danish nurse cohort.
Hundrup YA; Simonsen MK; Jørgensen T; Obel EB
Int J Epidemiol; 2012 Oct; 41(5):1241-7. PubMed ID: 21421694
[No Abstract] [Full Text] [Related]
17. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.
Kjaergaard AD; Ellervik C; Tybjaerg-Hansen A; Axelsson CK; Grønholdt ML; Grande P; Jensen GB; Nordestgaard BG
Circulation; 2007 Feb; 115(7):861-71. PubMed ID: 17309937
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for hormone replacement therapy after breast cancer?
Kwan K; Ward C; Marsden J
J Br Menopause Soc; 2005 Dec; 11(4):140-4. PubMed ID: 16354457
[TBL] [Abstract][Full Text] [Related]
20. The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
Pavlović RT; Janković SM; Milovanović JR; Stefanović SM; Folić MM; Milovanović OZ; Mamillapalli C; Milosavljević MN
Clin Breast Cancer; 2019 Dec; 19(6):e731-e740. PubMed ID: 31522958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
